logo
Covid-19 cases spike in India, Singapore and parts of Asia: Is it safe to travel? Here's what doctors advise

Covid-19 cases spike in India, Singapore and parts of Asia: Is it safe to travel? Here's what doctors advise

Hindustan Times20-05-2025
Covid-19 cases are showing a resurgence in Asian countries and cities such as Hong Kong and Singapore. India is also seeing a rise in cases, with top-effected states Kerala, Maharashtra, and Tamil Nadu leading the tally. The total number of active cases in India is 257 as of May 19, according to the Ministry of Health and Family Welfare's Covid-19 dashboard. Since May 12, Kerala reported 69 new cases, Maharashtra had 44, while Tamil Nadu added 34 new cases. Also read | Covid-19 cases rising, situation in India 'under control': 5 things we know about the fresh surge
India remains at risk due to global travel and large population density. In an interview with HT Lifestyle, Dr Subhashree Samantaray, associate consultant, infectious diseases, Manipal Hospital Bhubaneswar and Dr Nikhil Modi, senior consultant, respiratory and critical care, Indraprastha Apollo Hospitals shared precautions to follow given the current situation and everything else you need to know.
Dr Samantaray said, 'A new wave of Covid-19, circulating in southeast Asia with its epicentre in Singapore, has been in the news for the last few days. Along with Singapore, Hong Kong and Bangkok are also reporting a sudden rise in cases... such a peak can be due to the waning population immunity, non-compliance with the annual vaccination protocol, and the emergence of new sub-variants.'
She added, 'According to health authorities, this fresh wave is due to a new Omicron subvariant- LF.7 and NB.1.8, both subvariants of the JN.1 lineage, which was responsible for the last major global wave affecting the United States and parts of Europe in 2024. Even though this variant is not officially labelled as a variant of concern by WHO, the rapid spreading potential of the strain compared to previous variants has prompted Governments to make their surveillance and case-finding systems more stringent.'
Speaking about the rise in Covid-19 cases in India and other Asian countries recently, Dr Modi said, 'This is mostly because of a new version of the virus called the JN.1 variant. While this version spreads more easily, it is not causing more serious illness than before.'
According to Dr Samantaray, symptoms in the ongoing outbreak are reported mainly as 'persistent cough, sore throat, nausea and vomiting, conjunctivitis, and sometimes confusion'. She said, 'While most are recovering with home care, a few with risk factors may have worsening symptoms because of their underlying immunosuppressed status.'
Stressing there's 'no need for panic' amid rising Covid-19 cases in India, Dr Modi said, 'People who catch it are showing common symptoms like mild fever, sore throat, runny nose, tiredness, and sometimes cough. A few people may also feel sick in the stomach or lose their appetite. Most people are getting better at home within a few days.'
He added, 'Hospitals are not seeing a big increase in serious cases. There hasn't been a rise in people needing oxygen or being admitted to the ICU. Even people with other health issues are recovering with basic medicines like paracetamol, rest, and fluids. There's no need for panic.'
Considering such a scenario, should you delay non-urgent travel? Yes. Dr Modi said, 'If you are planning to travel and are generally healthy, it is safe to do so. Just follow simple safety steps — like washing your hands, avoiding very crowded places, and wearing a mask in closed spaces if needed. People who are older or have health problems like diabetes, heart disease, or breathing trouble should be more careful. They may want to delay travel if it's not urgent.'
Dr Samantaray added, 'It is advisable to restrict travel to these affected areas would be a wise call unless someone is vaccinated with the Covid-19 booster before planning to travel. What is peculiar about the surge is the season; while it's expected to witness a peak in winters, this variant has surged in summers, proving the sustainability of the virus in any season.'
Dr Samantaray said, 'Considering the fast-spreading capability of the strain, it is advisable to vaccinate all the individuals above six months of age, prioritising the high-risk groups, including the elderly ( above 60 years), those with diabetes or any chronic conditions, and also the health care and other front-line workers. As the Covid-19 vaccine available has JN.1 strain as its base formulation, it is expected to offer broader coverage against the circulating LF.7 and NB.1.8 strains, which are nothing but the variants of the latter.'
According to Dr Modi, 'vaccines are still helpful'. He said, 'Even though this new variant can partly escape the protection from earlier infection or vaccines, the vaccines are still doing a good job of preventing serious illness. If it has been more than six months since your last dose and you are in a high-risk group, it's a good idea to check with a doctor about getting a booster shot. In short, the virus is behaving more like the seasonal flu now. There is no reason to worry, but we should all stay alert, take care of our health, and protect those who are more likely to fall seriously ill.'
It is advisable to be vigilant about the symptoms that one may develop after acquiring the infection, and also seek medical attention if required, Dr Samantaray added. 'But what is more important is to follow social distancing, stringent hand hygiene, and using face masks and other precautions in crowds, along with vaccination, to prevent the spread of this rapidly spreading variant,' she said.
Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

covid vaccine: ‘They lied, billions were made': Doctor exposes COVID-19 ‘vaccine lies' at fiery Senate hearing - The Economic Times Video
covid vaccine: ‘They lied, billions were made': Doctor exposes COVID-19 ‘vaccine lies' at fiery Senate hearing - The Economic Times Video

Time of India

time15 minutes ago

  • Time of India

covid vaccine: ‘They lied, billions were made': Doctor exposes COVID-19 ‘vaccine lies' at fiery Senate hearing - The Economic Times Video

The Senate Homeland Security Committee hears heartbreaking testimonies from victims of alleged mRNA COVID vaccine injuries. One of the key voices was Dr. Robert Sullivan, an anesthesiologist, who not only shared his personal experience but also revealed startling findings from his research on adverse effects. The hearing titled "Voices of the Vaccine-Injured" sheds light on stories mainstream media ignored. Watch explosive moments and emotional appeals to lawmakers.

ASHA workers to hold three-day dharna in Bengaluru; demands include better pay and job security
ASHA workers to hold three-day dharna in Bengaluru; demands include better pay and job security

The Hindu

time3 hours ago

  • The Hindu

ASHA workers to hold three-day dharna in Bengaluru; demands include better pay and job security

ASHA (Accredited Social Health Activist) workers from BBMP, Bangalore urban and rural districts, will launch a three-day dharna at Freedom Park on Seshadri road, starting August 12, as part of a State-wide agitation demanding better wages and job security. Organised under the umbrella of various ASHA workers' unions, the protest aims to draw the attention of the Karnataka Chief Minister and Health Department to what workers call long-standing neglect of their contributions, especially in the post-pandemic era. Among their primary demands, the ASHA workers are seeking a monthly compensation of ₹10,000, effective from April 2025. This includes both the State-provided honorarium and the Central government's incentive portion. Workers argue that despite being the frontline force in delivering rural healthcare and playing a crucial role during COVID-19, their efforts remain under-recognised and underpaid. The unions have also urged the State government to increase the ₹1,000 honorarium currently provided to all ASHA workers, in line with hikes recently granted to other scheme-based workers in the State Budget. Another key demand is job security. ASHA workers are strongly opposing any move to remove them under the guise of 'rationalisation,' fearing mass displacement and loss of livelihood. Meanwhile, the government has directed the officials to take necessary steps to ensure that public health services are not disrupted. The government issued a circular on Monday instructing the officials of Health and Family Welfare department to convince the ASHA workers of the facilities provided and to persuade them to not participate in the 'illegal agitation'. 'Information about ASHA workers who were absent from duty in their district limits every day from August 12 to 14, 2025, should be submitted to the Commissionerate. Apart from medical emergency, all types of leave should be restricted of all officers and staff of the Health Department (permanent/contract). And, the details of the activities of the ASHA workers who participated in the dharna should be entered on the website,' stated the circular.

Ousted FDA vaccine chief Vinay Prasad returning to agency
Ousted FDA vaccine chief Vinay Prasad returning to agency

News18

time3 hours ago

  • News18

Ousted FDA vaccine chief Vinay Prasad returning to agency

Washington, Aug 11 (AP) A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of President Donald Trump. Dr Vinay Prasad is resuming leadership of the FDA centre that regulates vaccines and biotech therapies, a spokesperson for the Department of Health and Human Services said in a statement Monday. Prasad left the agency late last month after drawing ire of right-wing activists, including Laura Loomer, because of his past statements criticizing Trump. A longtime a critic of FDA's standards for approving medicines, Prasad briefly ordered the maker of a gene therapy for Duchenne's muscular dystrophy to halt shipments after two patient deaths. But that action triggered pushback from the families of boys with the fatal condition and libertarian supporters of increased access to experimental medicines. Prasad's decision to pause the therapy was criticized by The Wall Street Journal editorial board, former Republican Sen Rick Santorum and others. The FDA swiftly reversed its decision suspending the therapy's use. Loomer posted online that Prasad was 'a progressive leftist saboteur," noting his history of praising liberal independent Sen. Bernie Sanders. But Prasad has had the backing of FDA Commissioner Marty Makary and health secretary Robert F Kennedy Jr, who have both called for scrutinizing the use of COVID-19 vaccines. Under Prasad, the FDA restricted the approval of two new COVID-19 shots from vaccine makers Novavax and Moderna and set stricter testing requirements for future approvals. (AP) RD RD view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store